Faculty

Research

Systems

Infrastructure

Patient & Public Awareness

Working with Industry

Research Databases

About Us

News: 46 gene sequencing test for cancer patients on the NHS

Title

46 gene sequencing test for cancer patients on the NHS 

News Title

46 gene sequencing test for cancer patients on the NHS 

News Content

A pioneering multi-gene cancer test, which allows therapy to be genetically tailored to individuals’ tumours, is being tested on NHS patients for the first time. Cancer patients will have their tumours analysed for a wide range of genetic defects, using the test that classifies cancers according to the genetic mutations that drive them rather than simply by where they are in the body. The test detects mutations across 46 genes in cancer cells, which will allows doctors to choose the most effective treatment for cancer patients, depending on the type of mutation found. The test, which was launched through the NIHR Oxford Biomedical Research Centre, could transform the way cancers are treated in the future.

News Link

Oxford University news release 

News Date

25/03/2013 

Expires

26/04/2013 

Date Created

 

Date Modified

 
Attachments
Created at 25/03/2013 16:56  by Leonilde Yahyaoui 
Last modified at 25/03/2013 16:56  by Leonilde Yahyaoui